Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Company Profile Financials Financial Details

Financial Details

Highlights

Versant Ventures has made 386 investments. Their most recent investment was on
obfuscation
, when Dayra Therapeutics raised
obfuscation
.Versant Ventures has raised a total of
obfuscation
across 13 funds, their latest being Versant Venture Capital SPV I (SAB). This fund was announced on
obfuscation
and raised a total of
obfuscation
.Versant Ventures has made 58 diversity investments. Their most recent diversity investment was on
obfuscation
, when 858 Therapeutics raised
obfuscation
.Versant Ventures has had
obfuscation
exit, which was Firefly Bio. Versant Ventures has had
obfuscation
exits. Versant Ventures's most notable exits include Firefly Bio, Jade Biosciences, and  Insulet.
Lead Investments 108
Investments 386
Exits 
obfuscation
Funds 13

Investments

Number of Portfolio Organizations 189
Number of Investments 386
Versant Ventures has made 386 investments. Their most recent investment was on
obfuscation
, when Dayra Therapeutics raised
obfuscation
.
How many investments has this organization made over time?
Which industries has this organization most actively invested in?
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Dayra Therapeutics Logo
Dayra Therapeutics
Yes
Venture Round - Dayra Therapeutics Logo
Venture Round - Dayra Therapeutics
obfuscation
obfuscation
Dayra Therapeutics Logo
Dayra Therapeutics
Yes
Venture Round - Dayra Therapeutics Logo
Venture Round - Dayra Therapeutics
obfuscation
obfuscation
Dayra Therapeutics Logo
Dayra Therapeutics
Yes
Venture Round - Dayra Therapeutics Logo
Venture Round - Dayra Therapeutics
obfuscation
obfuscation
Dayra Therapeutics Logo
Dayra Therapeutics
Yes
Venture Round - Dayra Therapeutics Logo
Venture Round - Dayra Therapeutics
obfuscation
obfuscation
Dayra Therapeutics Logo
Dayra Therapeutics
Yes
Venture Round - Dayra Therapeutics Logo
Venture Round - Dayra Therapeutics
obfuscation

Funds Raised

Number of Funds 13
Total Fund Raised 
obfuscation
Versant Ventures has raised a total of
obfuscation
across 13 funds, their latest being Versant Venture Capital SPV I (SAB). This fund was announced on
obfuscation
and raised a total of
obfuscation
.
Announced Date  
Fund Name  
Money Raised  
obfuscation
Versant Venture Capital SPV I (SAB) Logo
Versant Venture Capital SPV I (SAB)
obfuscation
obfuscation
Versant Voyageurs III Logo
Versant Voyageurs III
obfuscation
obfuscation
Versant Vantage III Logo
Versant Vantage III
obfuscation
obfuscation
Versant Venture Capital IX Logo
Versant Venture Capital IX
obfuscation
obfuscation
Versant Voyageurs II Logo
Versant Voyageurs II
obfuscation
obfuscation
Versant Venture Capital VIII Logo
Versant Venture Capital VIII
obfuscation
obfuscation
Versant Vantage II Logo
Versant Vantage II
obfuscation
obfuscation
Versant Voyageurs I Logo
Versant Voyageurs I
obfuscation
obfuscation
Versant Venture Capital VII Logo
Versant Venture Capital VII
obfuscation
obfuscation
Versant Venture Capital VI, L.P. Logo
Versant Venture Capital VI, L.P.
obfuscation

Diversity Investments

Number of Diversity Investments 58
Versant Ventures has made 58 diversity investments. Their most recent diversity investment was on
obfuscation
, when 858 Therapeutics raised
obfuscation
.
Announced Date  
Organization Name  
Diversity Spotlight  
Funding Round  
Money Raised  
obfuscation
858 Therapeutics Logo
858 Therapeutics
Women Founded
Series B - 858 Therapeutics Logo
Series B - 858 Therapeutics
obfuscation
obfuscation
Firefly Bio Logo
Firefly Bio
Women Founded
Series A - Firefly Bio Logo
Series A - Firefly Bio
obfuscation
obfuscation
Tentarix Biotherapeutics Logo
Tentarix Biotherapeutics
Women Founded
Series B - Tentarix Biotherapeutics Logo
Series B - Tentarix Biotherapeutics
obfuscation
obfuscation
Launchpad Therapeutics Logo
Launchpad Therapeutics
Women Founded
Series A - Launchpad Therapeutics Logo
Series A - Launchpad Therapeutics
obfuscation
obfuscation
Jnana Therapeutics Logo
Jnana Therapeutics
Women Founded
Series C - Jnana Therapeutics Logo
Series C - Jnana Therapeutics
obfuscation
obfuscation
Ventus Therapeutics Logo
Ventus Therapeutics
Women Founded
Series C - Ventus Therapeutics Logo
Series C - Ventus Therapeutics
obfuscation
obfuscation
Tentarix Biotherapeutics Logo
Tentarix Biotherapeutics
Women Founded
Series A - Tentarix Biotherapeutics Logo
Series A - Tentarix Biotherapeutics
obfuscation
obfuscation
858 Therapeutics Logo
858 Therapeutics
Women Founded
Series A - 858 Therapeutics Logo
Series A - 858 Therapeutics
obfuscation
obfuscation
Lycia Therapeutics Logo
Lycia Therapeutics
Women Founded
Series B - Lycia Therapeutics Logo
Series B - Lycia Therapeutics
obfuscation
obfuscation
Jnana Therapeutics Logo
Jnana Therapeutics
Women Founded
Series B - Jnana Therapeutics Logo
Series B - Jnana Therapeutics
obfuscation

Exits

Number of Exits 
obfuscation
Versant Ventures has had
obfuscation
exit, which was Firefly Bio. Versant Ventures has had
obfuscation
exits. Versant Ventures's most notable exits include Firefly Bio, Jade Biosciences, and  Insulet.
Which industries has this organization had the most exits in?
Firefly Bio Logo
Firefly BioFirefly Bio is a biotechnology company that develops targeted cancer therapeutics based on antibody-drug conjugate (ADC) technology.
Jade Biosciences Logo
Jade BiosciencesJade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Insulet Logo
InsuletInsulet is a medical device company that offers an omnipod delivery system.
LENZ Therapeutics Logo
LENZ TherapeuticsLENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
RayzeBio Logo
RayzeBioRayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Jazz Pharmaceuticals Logo
Jazz PharmaceuticalsJazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
Veracyte Logo
VeracyteVeracyte develops molecular diagnostic tests to improve patient outcomes and lower healthcare costs.
Tempest Therapeutics Logo
Tempest TherapeuticsTempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Passage Bio Logo
Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Jnana Therapeutics Logo
Jnana TherapeuticsJnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|